These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 26519683)

  • 1. Strokes after cardioversion of atrial fibrillation--The FibStroke study.
    Palomäki A; Mustonen P; Hartikainen JE; Nuotio I; Kiviniemi T; Ylitalo A; Hartikainen P; Lehtola H; Luite R; Airaksinen KE
    Int J Cardiol; 2016 Jan; 203():269-73. PubMed ID: 26519683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of stroke after catheter ablation versus cardioversion for atrial fibrillation: A propensity-matched study of 24,244 patients.
    Noseworthy PA; Kapa S; Deshmukh AJ; Madhavan M; Van Houten H; Haas LR; Mulpuru SK; McLeod CJ; Asirvatham SJ; Friedman PA; Shah ND; Packer DL
    Heart Rhythm; 2015 Jun; 12(6):1154-61. PubMed ID: 25708883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality after stroke in patients with paroxysmal and chronic atrial fibrillation - The FibStroke study.
    Palomäki A; Kiviniemi T; Mustonen P; Odei C; Hartikainen JEK; Nuotio I; Ylitalo A; Hartikainen P; Biancari F; Airaksinen KEJ
    Int J Cardiol; 2017 Jan; 227():869-874. PubMed ID: 27639597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low stroke risk after elective cardioversion of atrial fibrillation: an analysis of the Flec-SL trial.
    Apostolakis S; Haeusler KG; Oeff M; Treszl A; Andresen D; Borggrefe M; Lip GY; Meinertz T; Parade U; Samol A; Steinbeck G; Wegscheider K; Breithardt G; Kirchhof P
    Int J Cardiol; 2013 Oct; 168(4):3977-81. PubMed ID: 23871349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation.
    Hellman T; Kiviniemi T; Nuotio I; Vasankari T; Hartikainen J; Lip GYH; Airaksinen KEJ
    Thromb Res; 2017 Aug; 156():163-167. PubMed ID: 28662483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of cardioversion in atrial fibrillation lasting less than 48 h without post-procedural anticoagulation in patients at low cardioembolic risk.
    Tampieri A; Cipriano V; Mucci F; Rusconi AM; Lenzi T; Cenni P
    Intern Emerg Med; 2018 Jan; 13(1):87-93. PubMed ID: 28025766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underuse of anticoagulation in stroke patients with atrial fibrillation--the FibStroke Study.
    Palomäki A; Mustonen P; Hartikainen JE; Nuotio I; Kiviniemi T; Ylitalo A; Hartikainen P; Airaksinen KE
    Eur J Neurol; 2016 Jan; 23(1):133-9. PubMed ID: 26263442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Events of Electrical Cardioversion Under Optimal Anticoagulation in Atrial Fibrillation: The Multicenter Analysis.
    Shin DG; Cho I; Hartaigh Bó; Mun HS; Lee HY; Hwang ES; Park JK; Uhm JS; Pak HN; Lee MH; Joung B
    Yonsei Med J; 2015 Nov; 56(6):1552-8. PubMed ID: 26446636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?
    Lehtola H; Hartikainen J; Hartikainen P; Kiviniemi T; Nuotio I; Palomäki A; Ylitalo A; Airaksinen KEJ; Mustonen P
    Clin Cardiol; 2018 May; 41(5):608-614. PubMed ID: 29745996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of outcomes after cardioversion or atrial fibrillation ablation in patients with differing periprocedural anticoagulation regimens.
    Kochhäuser S; Khaykin Y; Beardsall J; Juta R; Hache P; Trought K; Lenton-Brym T; Tsang B; Pantano A; Beardsall M; Wulffhart Z; Verma A
    Can J Cardiol; 2014 Dec; 30(12):1541-6. PubMed ID: 25475459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study.
    Airaksinen KE; Grönberg T; Nuotio I; Nikkinen M; Ylitalo A; Biancari F; Hartikainen JE
    J Am Coll Cardiol; 2013 Sep; 62(13):1187-92. PubMed ID: 23850908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the RHYTHM-AF study).
    Lip GY; Gitt AK; Le Heuzey JY; Bash LD; Morabito CJ; Bernhardt AA; Sisk CM; Chazelle F; Crijns HJ;
    Am J Cardiol; 2014 Feb; 113(3):480-4. PubMed ID: 24332698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation).
    Flaker G; Lopes RD; Al-Khatib SM; Hermosillo AG; Hohnloser SH; Tinga B; Zhu J; Mohan P; Garcia D; Bartunek J; Vinereanu D; Husted S; Harjola VP; Rosenqvist M; Alexander JH; Granger CB;
    J Am Coll Cardiol; 2014 Mar; 63(11):1082-7. PubMed ID: 24211508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study).
    Grönberg T; Hartikainen JE; Nuotio I; Biancari F; Ylitalo A; Airaksinen KE
    Am J Cardiol; 2016 Apr; 117(8):1294-8. PubMed ID: 26892448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of oral anticoagulation use with cardioversion in clinical practice.
    Geurink K; Holmes D; Ezekowitz MD; Pieper K; Fonarow G; Kowey PR; Reiffel JA; Singer DE; Freeman J; Gersh BJ; Mahaffey KW; Hylek EM; Naccarelli G; Piccini JP; Peterson ED; Pokorney SD
    Heart; 2021 Apr; 107(8):642-649. PubMed ID: 32591363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial Fibrillation Diagnosis Timing, Ambulatory ECG Monitoring Utilization, and Risk of Recurrent Stroke.
    Lip GY; Hunter TD; Quiroz ME; Ziegler PD; Turakhia MP
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative Strokes and Intracranial Bleeds in Patients With Atrial Fibrillation: The FibStroke Study.
    Palomäki A; Kiviniemi T; Hartikainen JE; Mustonen P; Ylitalo A; Nuotio I; Hartikainen P; Jaakkola J; Luite R; Airaksinen KE
    Clin Cardiol; 2016 Aug; 39(8):471-6. PubMed ID: 27240121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 Trial.
    Diener HC; Becher N; Sehner S; Toennis T; Bertaglia E; Blomstrom-Lundqvist C; Brandes A; Beuger V; Calvert M; Camm AJ; Chlouverakis G; Dan GA; Dichtl W; Fierenz A; Goette A; de Groot JR; Hermans A; Lip GYH; Lubinski A; Marijon E; Merkely B; Mont L; Nikorowitsch J; Ozga AK; Rajappan K; Sarkozy A; Scherr D; Schnabel RB; Schotten U; Simantirakis E; Vardas P; Wichterle D; Zapf A; Kirchhof P;
    J Am Heart Assoc; 2024 Sep; 13(17):e036429. PubMed ID: 39190564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of stroke or transient ischemic attack after atrial fibrillation ablation with oral anticoagulant use guided by ECG monitoring and pulse assessment.
    Riley MP; Zado E; Hutchinson MD; Lin D; Bala R; Garcia FC; Callans DJ; Cooper JM; Verdino RJ; Dixit S; Marchlinski FE
    J Cardiovasc Electrophysiol; 2014 Jun; 25(6):591-6. PubMed ID: 24533561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.